Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. (RPID) priced its initial public offering on Jul 16, 2021 at $20.00 per share, within its $18.00–$20.00 range, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $799.8M. J.P. Morgan was lead-left underwriter, joined by Morgan Stanley, TD Cowen and Stifel. Goodwin Procter advised the underwriters.

Rapid Micro Biosystems, Inc. provides automation solutions for manufacturing and releasing healthcare products such as biologics, vaccines, cell and gene therapies and sterile injectables. Its Growth Direct platform automates microbial quality control testing at the manufacturing line.

Status

IPO

Ticker

RPID

Exchange

Nasdaq Global Select

Priced

Jul 16, 2021

IPO price

$20.00

Price range

$18.00–$20.00

Market cap at IPO price

$799.8M

First filed

Jun 25, 2021

Underwriters

J.P. Morgan, Morgan Stanley, TD Cowen and Stifel

Underwriters' counsel

Goodwin Procter

Sector

Industrials & materials

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.